Are thyrotropin‐releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid‐induced respiratory depression?

Opioid‐induced respiratory depression (OIRD) is a potentially life‐threatening complication of opioid consumption. Apart from naloxone, an opioid antagonist that has various disadvantages, a possible reversal strategy is treatment of OIRD with the hypothalamic hormone and neuromodulator thyrotropin‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Algera, Marieke Hyke, Cotten, Joseph F., van Velzen, Monique, Niesters, Marieke, Boon, Martijn, Shoham, Daniel S., Dandrea, Kaye E., van der Schrier, Rutger, Dahan, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Invited Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137104/
https://www.ncbi.nlm.nih.gov/pubmed/35621218
http://dx.doi.org/10.1002/prp2.974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137104/
https://www.ncbi.nlm.nih.gov/pubmed/35621218
http://dx.doi.org/10.1002/prp2.974

Ejemplares similares